NurExone Biologic Inc.

NurExone está desarrollando una plataforma de terapia regenerativa con exosomas. Su programa principal se centra en las lesiones del sistema nervioso central, y estudios preclínicos de lesiones agudas de la médula espinal y del nervio óptico muestran recuperación funcional tras un ciclo corto de tratamiento mínimamente invasivo.

País

Israel

Sitio web

nurexone.com

Fundado

2020

Sociales

Fuente de información:

nurexone.com

Añadir a mi lista

Ejecutivos clave

Yoram Drucker

Co-Founder, VP Strategic Development & Chairman

Lior Shaltiel, PhD

Chief Executive Officer & Director

Industrias

Biotech

Agregue tu empresa

Disclaimer

The content of this website is not directed at or intended for persons in the United Kingdom or any other jurisdiction where the provision of the website or services would breach any applicable law or registration or would require any registration or license in any such jurisdiction. The content of this website should not be regarded as an invitation or inducement to engage in investment activity, to any person in the United Kingdom and investment opportunities described on this website are not intended to be acted upon by any persons in the United Kingdom.